Buy MDCX by Sep 2, 2026.

Posting some DD on Medicus Pharma (Nasdaq: MDCX), a clinical stage biotech trading around $0.30. Not a recommendation - sharing what I've found, do your own DD. **The company:** Medicus is developing SkinJect, a microneedle patch (doxorubicin containing microneedle arrays) that delivers chemo directly into skin cancer lesions - a potential non invasive alternative to surgery for basal cell carcinoma. Second asset is Teverelix, a next-gen GnRH antagonist for high CV risk prostate cancer and acute urinary retention. **The catalyst …